Technology | May 15, 2014

Mobile App Provides Life-Saving Assistance For Cardiac Patients

CathMaps+ debuts in Boston at AARP's Health [email protected]+ Tech Expo

CathMaps+ App Cath Lab Patient Engagement Mobile Devices

May 15, 2014 — CathMaps demonstrated how mobile technology can provide emergency assistance and peace of mind to millions of Americans at risk for a cardiac event. The AARP Health [email protected]+ Tech Expo showcases the latest in digital health technology designed to improve quality of life. The event is part of AARP's [email protected]+ National Event in Boston, May 8-10.

CathMaps+ is the world's first mobile application for people with elevated risk of a cardiac incident — particularly those who have a history of cardiac issues — that integrates critical health history and medical records with an interactive map of catheterization facilities (cath labs) throughout the world. The app is also HIPPA compliant.

"With the levels of heart disease on the rise in the U.S., the medical community must remain vigilant in our efforts to provide patients with tools and information that can help improve the quality of their lives," says Jack Stroh, an interventional cardiologist at Robert Wood Johnson University Hospital and St. Peter's University Hospital in New Jersey, and advisor to CathMaps+.

Approximately 715,000 Americans have a heart attack each year, according to the Centers for Disease Control. Nearly 30 percent of those have already suffered a heart attach. The CathMaps+ app ensures that patients quickly locate and are directed to a medical facility with a catheterization lab — wherever they may be traveling. They can securely access and share their medical history with the lab staff, saving critical time in treatment. They can also give permission for their information to be shared with loved ones, caregivers or emergency professionals.

"As a life or death condition, the idea of suffering a repeat incident is an almost constant concern. This app offsets patient anxiety, giving them peace of mind as they go about their daily lives," says Danny Oberman, founder and CEO of CathMaps+. "We see this as a valuable tool for cardiologist and the medical community as well. The AARP Health [email protected]+ Tech Expo is the perfect event to debut the app in the U.S."

Oberman founded CathMaps+ following his own cardiac incident in 2013. He combined his experience of living with an elevated risk of heart attack with his technology expertise to create a tool that is easy to use and functional in an emergency, while alleviating anxiety for cardiac patients.

CathMaps+, an Israeli-based technology company, is owned by Kickstart LLC, and is available for most Android and iOS users. The app is available in English and Spanish, with additional languages releases throughout 2014. It may be purchased from the App Store and Google Play.

For more information: www.cathmaps.com

Related Content

People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes. 

Feature | Cath Lab | October 03, 2019
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with pe
Two Stents Implanted in Democratic Presidential Candidate Bernie Sanders, suffers chest pain
News | Cath Lab | October 02, 2019 | Dave Fornell, Editor
October 2, 2019 — Democratic presidential candidate Sen.
Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival
News | Cath Lab | September 25, 2019
Ten-year survival rates are similar for bypass surgery and coronary stenting with drug-eluting stents in randomized...
Complete Revascularization Superior to Culprit Lesion-only Intervention
News | Cath Lab | September 10, 2019
An international randomized trial has shown that complete revascularization reduces major cardiovascular events...
The cath lab staff UH Portage Medical Center.

The cath lab staff UH Portage Medical Center.

Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...
FDA Grants Shockwave Medical Breakthrough Status for Coronary Intravascular Lithotripsy
News | Cath Lab | September 03, 2019
Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)...
Compound Could Help Improve Heart Attack Recovery
News | Cath Lab | August 27, 2019
Imagine there were a drug that you could take soon after a heart attack that could reduce damage by protecting healthy...
New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Overlay Init